UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...

"We're also providing a scalable blueprint to expand agentic automation across the enterprise, transforming how business users engage with ERP through seamless collaboration betwe ...

On March 12, 2026, investors weighed UiPath’s first full-year profit against slowing growth and divided Wall Street views.

UiPath stock sinks despite reporting its first-ever profit in Q4. A new buyback plan is failing to support PATH share price as well. Here's why the price action on Thursday does make sense.

Elon explicitly pushed back on today’s Business Insider “Macrohard stalled → pivot to Tesla” FUD. XAI minor staff churn, ...

Software demos and Pentagon records detail how chatbots like Anthropic’s Claude could help the Pentagon analyze intelligence ...

UiPath (PATH) stock slides after Q4 FY26 results as Needham upgrades to Buy on ARR and free cash flow growth; AI ARR hits $200M.

UiPath Inc PATH reported financial results for the fourth quarter of fiscal 2026 after the market close on Wednesday. Here’s a look at the key details from the report. UiPath shares are advancing ...

Dines spotlighted Maestro, UiPath's orchestration engine, and recent product wins, including a semiconductor company deploying agentic workflows in under two weeks and One New Zealand, which reduced a ...

UiPath Inc PATH reported better-than-expected financial results for the fourth quarter of fiscal 2026 after the market close on Wednesday. The company reported revenue of $481.11 million versus ...

Morgan Stanley analyst Sanjit Singh also trimmed his price target to $17 from $19. ・Analysts say fourth-quarter results met expectations but see limited near-term upside due to modest growth. ・UBS ...